Dorset care home named in top 100 for the UK
Trinity Manor Care Home in Sherborn was listed as one of the UK's Top 100 care homes out of more than 14,000 across the whole country by online care finder Lottie.
The inaugural Lottie Awards recognise and celebrate care homes across the UK that demonstrate exceptional commitment to residents, families and staff.
Will Donnelly, Co-Founder and CEO of Lottie, said: 'The launch of the Lottie Awards is about recognising the incredible dedication of care professionals who make a real difference in people's lives every day.
"To be named among the Top 100 from over 14,000 care homes nationwide is a huge achievement.
"These care homes are not just meeting residents' needs, they're redefining later living by creating vibrant and supportive communities that deliver exceptional care and experiences.'
Senior General Manager of Trinity Manor Care Home, Sohail Daniel, added: 'Every single one of us here at Trinity Manor is thrilled to be named one of the UK's Top 100 care homes, we're all absolutely delighted.
"It is so lovely for all our staff, and for our residents and their loved ones to have this recognition.
"Everyone here is a superstar and I couldn't be prouder of each and every one of them. It really is such wonderful news.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Midwife brings claim against trust after ‘Prevent referral over Palestine posts'
A midwife is bringing an employment claim against a hospital trust she worked for after it lodged a Prevent referral with police over her online support for Palestine and criticism of Zionism, her lawyers have said. Chelsea and Westminster Hospital NHS Foundation Trust made the referral to the Home Office's early intervention counter-terrorism programme, along with one to the Nursing and Midwifery Council regulator, a year after Fatimah Mohamied had resigned from her employment and following a complaint about her online activity from UK Lawyers for Israel (UKLFI), according to law firm Leigh Day. The mother-of-two, who lives in London, alleges the referrals breach her rights under the Equality Act 2010 and constitute post-employment harassment and/or discrimination. She said: 'I have been subjected to a concerted and targeted effort to intimidate, harass and punish me into silence for my Palestinian advocacy and criticism of Zionism. 'I am taking legal action against my former employer to finally seek accountability for a campaign of harassment against me in the midst of a live genocide perpetrated by the Israeli state – I will not accept the attempts to silence me and those like me. 'Healthcare workers in the NHS have the right to critique a colonial political ideology that has upheld an illegal occupation for decades and is responsible for violating universal values of health.' A complaint was lodged on October 8 2023 about Ms Mohamied's social media posts in which she voiced her support for Palestinian people and her opposition to Zionism in the wake of the October 7 attacks in Israel, according to Leigh Day. Her line manager asked her to consider deleting the posts or her account but she refused to do so. Three further complaints were made about the midwife's social media posts and on December 20 2023 the trust received a letter from UKLFI accusing Ms Mohamied of expressing support for Hamas. In early January the following year, the trust's director of maternity told Ms Mohamied that if they received 'more emails or letters of concern' her actions could be considered misconduct. Ms Mohamied, who was employed as a 'cultural safety lead' midwife and who had worked at the trust since June 2019, resigned in March last year. In March of this year, the trust received a second letter from UKLFI which launched further complaints about further social media posts and accused Ms Mohamied of anti-semitism, bullying and harassment and of stirring up racial hatred against Jews and Israelis. Towards the end of the month, the trust referred Ms Mohamied to the Nursing and Midwifery Council and then to the Metropolitan Police under Prevent over her online activity. Both referrals were dismissed, and Leigh Day said in a letter to the trust that the regulator and police each assessed Ms Mohamied's posts 'amounted to lawful expression of her beliefs and did not present cause for concern'. Liana Wood, partner at the law firm, said: 'We say the trust's referrals against Fatimah, made a year after she had stopped working for them, were an entirely disproportionate response to her lawful expressions of belief on her personal blog and social media accounts. 'Fatimah's case, which has parallels with other cases we have seen recently in the NHS, highlights the need for employers to resist pressure from lobby groups in such cases, and to carefully consider any potential infringement on an individual's rights before taking action against them.' The hospital trust has been contacted for comment.
Yahoo
4 hours ago
- Yahoo
Gym with wellbeing focus welcomes lottery boost
A gym set up with a focus on the wellbeing of body and mind has been awarded a £14,000 lottery grant to develop its work. The Soma Space in Oswestry was established two years ago by Kevin Braddock, a psychotherapist and fitness instructor, and Jo Hazell-Watkins, a personal trainer and trauma-informed strength coach. It offers combined strength training and psychotherapy, and prospective clients can refer themselves or be referred by social care workers and GPs. Mr Braddock said the gym was there to help people start exercising, know what to do and where, and who with, adding that everyone knew about the benefits of exercise on mental health, but the question for many was " how do you do it". The 12 lesson online Movement for Mental Health programme, which has received the lottery support, focuses on six basic movements designed to boost mental health. Mr Braddock said: "Our tagline is movement for mental health. "We're interested in is the benefits of exercise on mental health, which sort of everybody knows about, but the question is how do you do it. "For somebody who might be struggling with mental illness or poor mental health, how do they go about starting to exercise? What do they do? Who with? Where?" 'A sense of relief' "As long as you've got a couple of metres square, or a garden, or a space where you feel comfortable to be in, you can start moving," Ms Hazell-Watkins said. People could try a set of 10 squats just by sitting on a chair and getting back up again, or go for a walk 10 times around their garden," she added. "A private space, no special clothes and anything that puts a little bit of demand on your body is a good start," she said. Imogen, who uses to Soma Space, had always been nervous of going to a gym because she thought it would be "full of people who were super fit and super strong and I didn't consider myself to be one of those people". She said her nerves soon evaporated, adding: "It's helped me certainly with low moods and feeling depressed... When I leave there I feel a sense of relief. I just feel calmer and more at ease." Follow BBC Shropshire on BBC Sounds, Facebook, X and Instagram. More on this story Gym-goers quizzed as part of mental health study 'Exercise for your mental health, not looks' Mental health gyms: A place to train your brain Regular exercise 'best for mental health' Related internet links The Soma Space
Medscape
4 hours ago
- Medscape
Early Access to Weight Loss Jabs in NICE Diabetes Plan
People with type 2 diabetes (T2D) in England could be offered earlier access to newer treatments, including weight loss jabs, under draft guidance from the National Institute for Health and Care Excellence (NICE). The guidance, described as the 'biggest shake-up in care for a decade', would see a shift from a one-size-fits-all approach to a focus on personalised treatment to prevent heart failure, heart attacks, and other serious complications. Expanded Use of SGLT-2 Inhibitors The draft guidance recommends expanding access to sodium-glucose co-transporter-2 (SGLT-2) inhibitors, including canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin. Currently prescribed as a second-line option, SGLT-2 inhibitors would be available as a joint first-line treatment alongside metformin. They may also be used as monotherapy in patients intolerant to metformin. SGLT-2 inhibitors are once-daily tablets that selectively block the SGLT-2 cotransporter in the proximal renal tubule, responsible for reabsorbing about 90% of filtered glucose. This lowers the renal glucose threshold, increasing urinary glucose excretion and inducing mild osmotic diuresis. However, a 2024 NICE analysis of nearly 590,000 people with T2D in England found under-prescribing of these drugs, particularly among women, older adults, and Black patients. Only 20% of patients with atherosclerotic cardiovascular disease received SGLT-2 inhibitors, with prescribing rates declining in older age groups. NICE estimates that wider use of SGLT-2 inhibitors could save nearly 22,000 lives once uptake reaches 90%. Earlier Access to GLP-1 Agonists The draft guidance also recommends earlier use of glucagon-like peptide-1 (GLP-1) receptor agonists such as liraglutide or semaglutide. These drugs, previously reserved for later stages of disease, would be considered earlier in treatment for selected groups. NICE further supports wider adoption of digital health tools, including continuous glucose monitoring and community-based digital care. Personalised Treatment Approaches The guidance proposes tailored treatment strategies based on patient characteristics and comorbidities: Adults with cardiovascular disease should receive triple therapy (metformin, an SGLT-2 inhibitor, and a GLP-1 receptor agonist) Those with early-onset T2D (diagnosed before age 40) should receive dual therapy before considering a GLP-1 receptor agonist Patients with obesity or chronic kidney disease should have specific combinations based on their condition and kidney function, respectively. Adults with clinical frailty should start with metformin monotherapy. Professor Jonathan Benger, deputy chief executive and chief medical officer at NICE, said the draft guidance marks a 'significant evolution' in diabetes care. 'The evidence shows that certain medicines can provide important cardiovascular benefits, and by recommending them as part of initial treatment, we could help prevent heart attacks, strokes, and other serious complications before they occur,' he said. Burden of Diabetes in the UK Approximately 4.6 million people in the UK have diabetes, with 90% diagnosed with T2D. Diabetes UK estimates that a further 1.3 million may be undiagnosed. The condition costs the NHS £1 million per hour, with 60% of spending linked to complications. Each week, diabetes contributes to more than 930 strokes, 660 heart attacks, and nearly 2990 cases of heart failure. Douglas Twenefour, head of clinical at Diabetes UK, welcomed the draft guidance. 'The majority of people with T2D are not currently taking the most effective medication for them, putting them at risk of devastating diabetes-related complications,' he said. 'Tailoring treatment based on individual risk could protect thousands against heart attacks and kidney disease.' Waqaar Shah, a GP partner at Chatfield Health Care in London and chair of the NICE guideline committee, said that these recommendations 'could help reduce health inequalities while providing better outcomes for everyone'. Implementation and Safety The draft guidance remains open for public consultation until 2 October. NICE will review feedback before publishing final recommendations. The guidance aims to promote equitable access to recommended therapies, supported by local training initiatives. Healthcare professionals have also stressed the need for safe prescribing of SGLT-2 inhibitors, which carry risks including diabetic ketoacidosis (DKA). Before starting treatment, providers should assess whether patients have previously experienced DKA, have acute illness, or follow very low-carbohydrate or ketogenic diets.
